OptimizeRx (OPRX) Enterprise Value (2012 - 2026)

OptimizeRx has disclosed Enterprise Value across 15 years of filings, most recently posting $83.6 million for Q2 2026.

• In Q2 2026, Enterprise Value fell 64.26% year-over-year to $83.6 million; the TTM figure through Jun 2026 stood at $83.6 million (down 64.26% YoY), while the FY2025 annual figure was $206.6 million, up 170.8% from the prior year.
• Enterprise Value came in at $83.6 million for Q2 2026 at OptimizeRx, down from $97.7 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of $586.2 million in Q1 2022 to a low of $76.3 million in Q4 2024.
• Average Enterprise Value over 5 years is $213.7 million, with a median of $197.2 million recorded in 2023.
• Year-over-year, Enterprise Value sank 86.6% in 2022 and jumped 187.6% in 2025.
• Over 5 years, Enterprise Value stood at $233.1 million in 2022, then rose by 5.53% to $246.0 million in 2023, then plunged by 68.98% to $76.3 million in 2024, then soared by 170.8% to $206.6 million in 2025, then sank by 59.52% to $83.6 million in 2026.
• Per Business Quant data, the three most recent Enterprise Value figures were $83.6 million in Q2 2026, $97.7 million in Q1 2026, and $206.6 million in Q4 2025.